Mar 18, 2021
News & Events
Press Releases
Mar 4, 2021
Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
Mar 3, 2021
Salarius Announces Proposed Public Offering of Common Stock
Feb 24, 2021
Salarius Pharmaceuticals Initiates Expansion Stage of Phase 1/2 Clinical Trial of Seclidemstat in Patients with Ewing Sarcoma and Ewing-Related Sarcomas
Events
NobleCon17: Panel Discussion on Targeted Cancer Therapies
During the Noble Capital Markets’ 17th Annual Small & Microcap Investor Conference, Dr. Daniela Santiesteban, Director of Research and Business Development at Salarius Pharmaceuticals, will participate in a virtual panel discussion highlighting the future of targeted cancer therapies. The panel...
Biotech Showcase Digital
https://informaconnect.com/biotech-showcase/registration-options/
A.G.P.’s Virtual Healthcare Symposium
Salarius Pharmaceuticals to Report Third Quarter 2020 Financial Results
Conference Call Information: Interested participants and investors may access the conference call by dialing either: (833) 423-0481 (U.S.) (918) 922-2375 (international) Conference ID: 1277839
In the News
Houston Business Journal